Levine Mark S.
Immunovant, Inc. · Chief Legal Officer
Levine Mark S. is listed in filings as Chief Legal Officer at Immunovant, Inc.. This profile follows SEC Form 4 activity through Nov 22, 2024, including sale activity. Recent filings connect the profile to Immunovant, Inc. (IMVT). The current snapshot covers public activity from Jul 19, 2024 to Nov 22, 2024. Reported amounts are shown as $92.9K to $82.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $129k4.4k shares | SellOct 23, 2024 | $29.53 | $38.96 | |
| $82k2.9k shares | SellOct 16, 2024 | $28.79 | $38.96 | |
| $4.2k131 shares | SellAug 21, 2024 | $32.32 | $38.96 | |
| $101k3.2k shares | SellAug 21, 2024 | $31.84 | $38.96 | |
| $111k4k shares | SellJul 24, 2024 | $27.76 | $38.96 | |
| $4.5k147 shares | SellJul 17, 2024 | $30.55 | $38.96 | |
| $70k2.4k shares | SellJul 17, 2024 | $29.64 | $38.96 |